Skip to main content
Study

Toward safer opioid prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial.

Cedillo G, George MC, Deshpande R. et al. Toward safer opioid prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial. Addict Sci Clin Pract. 2022;17:28. doi: 10.1186/s13722-022-00311-8

Save
Print
June 22, 2022
Cedillo G, George MC, Deshpande R, et al. Addict Sci Clin Pract. 2022;17(1):28.

In 2016, the Centers for Disease Control (CDC) issued an opioid prescribing guideline intended to reverse the increasing death rate from opioid overdoses. This study describes the development, implementation, and effect of a safe prescribing strategy (TOWER) in an HIV-focused primary care setting. Providers using TOWER were more adherent to the CDC guidelines, with no worsening patient-reported outcome measures.

Save
Print
Cite
Citation

Cedillo G, George MC, Deshpande R. et al. Toward safer opioid prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial. Addict Sci Clin Pract. 2022;17:28. doi: 10.1186/s13722-022-00311-8